Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Carisoprodol bulk supplier for pharma manufacturers

Carisoprodol 250 mg, 350 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 250 mg, 350 mg

Reference Brands: Soma (USA/EU)

Category: Analgesic

Carisoprodol is a centrally acting muscle relaxant used to relieve discomfort associated with acute musculoskeletal conditions such as muscle spasms, strains, and sprains. It works by blocking pain sensations between the nerves and the brain. Carisoprodol is usually prescribed for short-term use (up to 2–3 weeks) in combination with rest, physical therapy, and other treatments. It is available as oral tablets in strengths of 250 mg and 350 mg.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Carisoprodol? List it or send an offer →

Product Description:

Carisoprodol is a centrally acting skeletal muscle relaxant used for the short-term relief of acute musculoskeletal pain and discomfort associated with strains, sprains, and other muscle injuries. It is typically prescribed as part of a broader treatment plan that may include rest, physical therapy, and other supportive measures. After oral administration, the effect generally begins within about 30 minutes and may last up to six hours, helping reduce muscle spasm and improve mobility during the recovery period. Carisoprodol works by affecting communication between nerves in the central nervous system, leading to muscle relaxation and pain relief rather than acting directly on the muscles themselves. It is mainly intended for short-duration use due to the potential for dependence and sedation-related side effects. The product is commonly available in tablet form in multiple strengths and is marketed under several brand names globally, including Soma. Proper medical supervision is recommended to ensure safe and appropriate use.

Controlled medicine — licensed supply only

This product is controlled in many countries under narcotic, psychotropic, precursor or other drug laws, which vary by country. We supply only licensed buyers holding any import certificate, permit or authorisation their national authority requires, and the Indian manufacturer or exporter must hold the required licences. In India, each export of a narcotic drug or psychotropic substance needs an export authorisation, and export of ephedrine, pseudoephedrine or their preparations a No Objection Certificate, from the Narcotics Commissioner (Central Bureau of Narcotics). We verify permits before quoting.

Carisoprodol — third party manufacturing & bulk supply

Carisoprodol 250 mg, 350 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Carisoprodol is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Carisoprodol listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Carisoprodol →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Carisoprodol is used as a muscle relaxant to relieve discomfort caused by acute musculoskeletal conditions, such as muscle strains, sprains, and back pain. It is intended for short-term use along with rest, physical therapy, and other measures.

Carisoprodol is a centrally acting skeletal muscle relaxant. It works by affecting the communication between nerves in the central nervous system to produce muscle relaxation and relieve pain, but it does not directly act on the muscles themselves.

Common trade names include Soma, Vanadom, Myol, and Carisoma, depending on the country.

Carisoprodol is manufactured by several pharmaceutical companies, including Meda Pharmaceuticals and Mallinckrodt Pharmaceuticals, among others.

The generic name is carisoprodol.

Brand names include Soma, Vanadom, Myol, and Carisoma, depending on regional availability.

Carisoprodol is manufactured in various countries including the USA, India, and parts of Europe, with brand availability varying by region.

Related Products

Alfentanil

Strength:
500 mcg/mL

Form: Injection

Reference Brands: Alfenta (USA), Rapifen (EU)

View Details
Nabumetone Tablet

Strength:
500 mg, 750 mg, 1000 mg

Form: Tablets

Reference Brands: Relafen (USA/EU), Relifex (EU/UK)

View Details
Dexketoprofen

Strength:
12.5 mg, 25 mg,

Form: Tablets / Oral solution

Reference Brands: Enantyum (EU), Ketesse (EU)

View Details
Tolfenamic Acid

Strength:
200mg

Form: Capsules

Reference Brands: Clotam (EU)

View Details
Ketorolac Tromethamine Tablet

Strength:
10 mg

Form: Tablet

Reference Brands: Toradol (USA/EU)

View Details
Aceclofenac Injection

Strength:
75mg/ml, 150 mg/ml

Form: Injection

Reference Brands: -

View Details
Thiocolchicoside Injection

Strength:
4 mg, 8mg

Form: Injection

Reference Brands: Muscoril Injection (EU), Coltramyl Inj

View Details
Thiocolchicoside Capsules

Strength:
4 mg, 8 mg

Form: Capsules / Gel/Cream

Reference Brands: Coltramyl (EU), Muscoril

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us